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insurance coverage (OR, 1.768; CI,1.745–1.792)and those having higher income 
(OR,1.168;CI,1.155–1.182)were found to have higher odds of using inhaled cortico-
steroids when compared to uninsured and people from low income categories respec-
tively. Aside from these, disease severity also predicted the use of controller drug. 
Patients with increased severity had higher odds of using ICSs (OR, 1.552; CI, 
1.537–1.568). The ﬁndings held true even after adjusting for other demographic 
factors. CONCLUSIONS: Underuse of ICSs continues to be a problem in asthma 
patients. This not only makes the control of disease difﬁcult but shoots up the health-
care expenditure. The study was successful in ﬁnding out vulnerable populations that 
can be targeted for inhaled corticosteroids use. The importance of adherence to treat-
ment and inhaled corticosteroids use are issues that need to be addressed.
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THE IMPACT OF THE FDA’S RISK EVALUATION AND MITIGATION 
STRATEGIES (REMS) INITIATIVE ON PRESCRIPTION PATTERN FOR 
DRUGS APPROVED UNDER THE REMS PROGRAM AND RELEVANT 
NON-REMS COMPETITORS
Horowicz-Mehler N1, Sepulveda B1, White C1, Doyle J2
1Quintiles, Hawthorne, NY, USA, 2Quintiles Global Consulting, Hawthorne, NY, USA
OBJECTIVES: To assess the impact of REMS approval on prescription pattern for 
three oral drugs used to treat common chronic conditions. We assessed relative impact 
on prescription volume for REMS-approved drugs against relevant competitors not 
requiring REMS. We described these trends over the 2006–2009 period including the 
9/27/2007 implementation of the REMS initiative. METHODS: We paired two top 
prescribed drugs for the treatment of asthma (Advair/Singulair), diabetes (Actos/
Avandia) and insomnia (Ambien/Lunesta). Each pairing included a REMS-approved 
drug (Advair, Actos and Ambien). We focused on the months leading to and following 
REMS approvals. For each pairing, volume of total prescriptions (TRx), new prescrip-
tions (NRx) and prescription switches (SRx) were collected using the Verispan’s 
VONA database. Statistical analyses were performed using one-way ANOVA. 
RESULTS: There were no signiﬁcant changes (p < 0.05) in the volume of TRx, NRx 
and SRx for Advair or Actos prior to or following approval. However, Ambien TRx 
were signiﬁcantly higher during and after the last quarter of 2008 compared to previ-
ous months (p = .008) while SRx were lower (p = 0.04). This increase did not come 
to the expense of Lunesta whose prescription volume stayed constant over the time 
period considered. CONCLUSIONS: The fear that additional safety requirements 
could be detrimental to drug prescriptions was not conﬁrmed in our analyses. In fact, 
FDA requirement for REMS approval appeared to impact prescription volume favor-
ably for one of the drugs considered. One possible explanation is the potential for 
increased interactions with providers thus the ability to better position the drug clini-
cally. However, these trends were observed with less than a two-year period post-
approval and only for a handful of drugs and conditions. Additionally, the differential 
impact of various REMS components such as medical guide and communication plan 
should be further investigated.
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NATIONAL ANTI-ALLERGIC DRUG UTILIZATION PATTERNS IN 
ADULTS WITH ALLERGIC RHINITIS: NATIONAL AMBULATORY  
CARE SURVEY RESULTS.
Goyal RK, Patel HK, Sangani D, Aparasu RR
University of Houston, Houston, TX, USA
OBJECTIVES: To examine recent anti-allergic drug utilization patterns in adult 
patients with allergic rhinitis using National Ambulatory Care Survey data. 
METHODS: Data for this study was obtained from the 2006 and 2007 National 
Ambulatory Medical Care Survey (NAMCS) and National Hospital Ambulatory 
Medical Care Survey (NHAMCS) public use data ﬁles. Visits with a primary diagnosis 
of allergic rhinitis in adults (age >18 years) were identiﬁed. Descriptive weighted 
statistics was used to examine utilization patterns of various anti-allergic medications. 
A multivariate survey logistic was conducted to determine demographic and geo-
graphic variations associated with anti-allergic medication use in patients with allergic 
rhinitis. RESULTS: Allergic rhinitis accounted for 18.6 million adult ambulatory care 
visits in the United States. The majority of the visits were made by females (61.6%), 
whites (84.8%), and involved specialists (59.9%). Anti-allergic medications were 
prescribed in 55.1% (95%CI 39.2% −71.0%) of the total diagnosed visits. Antihis-
tamines were the most commonly prescribed anti-allergic medication (37.4%) (95%CI 
32.4%-46.5%) followed by intranasal steroids (28.3%) (95%CI 23.2%-31.8%). 
Topical nasal antihistamines and decongestants (7.8%) (95%CI 2.7%-9.9%), leukot-
rienes (6.3%) (95%CI 5.2%-6.8%), corticosteroids (3.4%) (95%CI 1.3%-4.3%), and 
oral decongestants (1.52%) (95%CI 0.4%-2.1%) were the least prescribed anti-
allergic medications. The multivariate logistic regression revealed that geographic 
region of the ofﬁce visits was signiﬁcantly associated with medication use. Outpatient 
visits in the Midwest (Odds Ratio (OR) 5.16, 95%CI 1.50–17.67), South (OR 6.3, 
95%CI 2.03–19.5), and West (OR 9.16, 95%CI 2.39–35.11) regions were more likely 
to be prescribed anti-allergic medications compared to those in the Northeast region. 
CONCLUSIONS: Anti-allergic medications were prescribed in over half of adult 
allergic rhinitis visits in the U.S. The ﬁndings highlight geographical variations in 
anti-allergic medication use for allergic rhinitis. Comprehensive research is needed to 
understand the reasons for geographic variation in the medication use for allergic 
rhinitis.
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IMPACT OF THE UK PUBLIC SMOKING BAN ON THE PRESCRIBING OF 
SMOKING CESSATION THERAPY IN PRIMARY CARE–A THIN 
DATABASE STUDY
Blak BT, Hards M, Thompson M, Dattani H
CSD EPIC, London, UK
OBJECTIVES: Over-the-counter nicotine replacement purchases increased immedi-
ately after the public smoking ban introduction in Scotland. The study objective was 
to evaluate the impact of the smoking bans throughout the UK on smoking cessation 
prescriptions (SCPs) or related general practice contacts (GPCs) in primary care. 
METHODS: Monthly data on SCPs (nicotine replacement therapy, bupropion, vareni-
cline) and GPCs were obtained from The Health Improvement Network (THIN) 
database, which holds anonymised longitudinal UK primary care data, 24 months 
before and after the ban in England (January 7, 2007), Wales (February 4, 2007), 
Scotland (March 26, 2006) and Northern Ireland (NI) (April 30, 2007). The percent-
age of active patients with ≥1 SCP and the percentage of GPCs which were smoking 
cessation-related were evaluated. Mann-Whitney tests compared percentages before 
and after the ban. RESULTS: Within each country SCPs increased slightly after the 
smoking ban, for example during the total 48 months 431,675 SCPs were prescribed 
in England, with 48.7% prescribed before the ban and 51.3% after. The median 
percentage of patients with ≥1 SCP increased slightly after the ban—in England the 
median was 0.28% before and 0.31% after, with no evidence of a difference (p = 
0.18), in Wales 0.36% and 0.49% (p = 0.001) respectively, Scotland 0.36% and 
0.37% (p = 0.85), and NI 0.48% and 0.54% (p = 0.09). The median percentage of 
GPCs decreased slightly—in England it was 1.87% before and 1.57% after, Wales 
2.08% and 1.81% respectively, Scotland 2.70% and 1.64%, and NI 2.95% and 
2.34%. There was evidence of a difference (p < 0.0001) in each country. CONCLU-
SIONS: The ban did not seem to impact smoking cessation activity in primary care 
greatly. Even though only signiﬁcant for Wales, the slight increase in patients with 
SCPs may be owing to the ban. The decrease in smoking-related GPCs could be owing 
to patients being referred to or seeking support outside of primary care.
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PRESCRIBING ANTIBIOTICS FOR ACUTE RESPIRATORY TRACT 
INFECTIONS BY PRIMARY CARE PHYSICIANS IN NEW DELHI, INDIA
Kotwani A1, Roy Chaudhury R2, Holloway K3
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OBJECTIVES: In the absence of community-based databases on antibiotic use in 
developing countries recently a methodology was established for surveillance of anti-
biotic use at New Delhi by conducting ‘Exit Interviews’ of the patients. This study 
was conducted to obtain information on current prescribing rates of antibiotics in 
acute respiratory illnesses (ARI), a condition where misuse of antibiotics is common. 
METHODS: Antibiotic use data was collected from public and private sector facilities 
from four municipal wards (residential localities) around a tertiary care hospital where 
the antibiotic resistance work was being conducted. For public sector, 8 dispensaries 
(primary health care) and 2 secondary care level facilities were enrolled. For private 
sector, 20 willing and cooperative general practitioners and specialists practising in 
the chosen areas were selected. Patients after consultation with prescriber were asked 
if they had cough/common cold/sore throat (symptoms of ARI). Patients with any of 
these symptoms were enrolled for exit interview and his/her prescription was moni-
tored. Antibiotic use data was collected per month over one year (December 
2007-November 2008).The percentage of patients receiving antibiotic and pattern of 
consumption for various antibiotics was analysed. RESULTS: At public facilities 
45.3% (746/1646) and at private facilities 56.7% (259/457) of patients with ARI were 
prescribed at least one antibiotic. In public sector, macrolides (29.3%), penicillins 
(26.3%), and cephalosporins (16.2%) and in private sector, cephalosporins (40%), 
ﬂuoroquinolones (21.7%), and penicillins (19.7%) were mainly prescribed. At public 
facilities, main members from macrolides were roxithromycin and erythromycin; for 
penicillins, amoxicillin and amoxicillin+clavulinic acid; for cephalosporins, cefuroxime 
and cephalexin were used. At private clinics, for cephalosporins, cefuroxime, cefpo-
doxime proxetil, ceﬁxime, ceﬁxime+clavulinic acid; for ﬂuoroquinolones, levoﬂoxacin 
and oﬂoxacin; and for penicillins group amoxicillin+clavulinic acid were prescribed. 
CONCLUSIONS: Over-prescription and irrational use of antibiotics was seen in ARI. 
In-depth behaviour study for prescribers and strategies to manage ARI are needed.
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ANTIBIOTIC PRESCRIBING FOR ACUTE RESPIRATORY TRACT 
INFECTIONS IN ADULT PRIMARY CARE: IS GOOD INSURANCE BAD 
FOR ANTIBIOTIC PRESCRIBING?
Zhang J1, Tao J2
1Virginia Commonwealth University, Richmond , VA, USA, 2Virginia Commonwealth 
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OBJECTIVES: Substantial overuse of newer broad-spectrum antibiotics has been a 
grave public health concern as it results in drug resistance and substantial health care 
costs. Little is known about how health insurance status is related with the prescribing 
of antibiotics at the adult primary care. We aim to assess the relationship between 
broad-spectrum antibiotic prescribing and patients’ insurance status in treatment of 
acute respiratory tract infections (ARTI) in adult primary care using a nationally 
representative sample. METHODS: We analyzed 2006 National Ambulatory Medi-
care Care Survey, for adult aged 18 years or older cared for ARTI. Those patients 
with a concomitant diagnosis with other common outpatient infections that might be 
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treated with antibiotics were excluded. Analysis was restricted to those patient visita-
tion cared by physician specialty with general practice, family practice, and internal 
medicine. Multivariate logit regression analysis was performed to assess the relation-
ship between patient insurance status and the prescribing of broad-spectrum antibiot-
ics controlling for age, gender, race and ethnicity, physician specialty, and 
comorbidities. RESULTS: Of 851 adults patients care for ARTI, 38% were prescribed 
one or more broad-spectrum antibiotics. In multivariate regression analysis, compared 
to those with private insurance, those with Medicaid, a public insurance program for 
low-income Americans, was associated with lower likelihood of prescribing of broad-
spectrum antibiotics (adjusted odds ratio (OR) 0.496, p = 0.003), so were those 
without health insurance (adjusted OR 0.499, p = 0.028), and those with Medicare, 
a public insurance program for the elderly or disabled adults (adjusted OR 0.666, p 
= 0.091). CONCLUSIONS: In the case of ARTI, those with private insurance were 
substantially more likely to be prescribed with broad-spectrum antibiotics, where the 
society may be better off if such overuse of antibiotics could be reduced.
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INTEGRATED EDUCATIONAL PROJECT WITH INDIVIDUAL FEEDBACK 
FROM CLAIMS DATA LEADS TO IMPROVED ANTIBIOTIC 
PRESCRIPTION AND RESISTANCE DECREASE
Hupkova H1, Foltan V2, Hroncova D3, Gezo M1
1General Health Insurance Fund, Bratislava, Slovak Republic, 2Comenius University, Bratislava, 
Slovak Republic, 3Mediforum, Non-commercial Educational Center of GSK, Bratislava, Slovak 
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OBJECTIVES: Increasing antibiotics costs and resistance led to establishment of 
educational project S-MedDial under guarantee of the General Health Insurance Fund 
and related professional associations. The project evaluates prescription habits in 
respiratory infections, monitors antibiotics resistance and provides individual feedback 
to pediatricians. Introduction of new indexes and summary quality bar from selected 
eight indexes has enhanced comparison among physicians and their willingness to 
improve. METHODS: In the last round of the project the antibiotic prescription was 
analyzed for 97 doctors in 7 Slovak regions based on the retrospective claims data 
from September 2007 to March 2008 and compared with previous season data. 
Individual feedback was provided to practitioners during regional meetings together 
with expert presentations and educative leaﬂets. RESULTS: Every second child with 
respiratory infection was treated with antibiotics. The most frequent drugs in DDD 
were macrolides (22.6%), followed by beta-lactamase sensitive penicillins (19.5%) 
and cephalosphorines (18.4%). Best pediatricians (20% of the group) were signiﬁ-
cantly different compared to the rest in majority of the quality bar indexes: less 
patients treated with ATB (31% vs. 51%); lower proportion of ATB in treatment (in 
EUR: 51% vs. 73%, in DDD: 28% vs. 51%); lower ATB costs per patient (−15%); 
lower aminopenicillins usage in acute tonsillopharyngitis (6% vs. 16%); lower ATB 
ratio in acute sinusitis (43% vs. 57%); however high ratio of macrolides was the 
problem across all groups. Higher prescription quality and lower ATB costs correlated 
together. There was signiﬁcant decrease of ATB costs induced by one pediatrician 
during six years of the project (−50%). CONCLUSIONS: S-MedDial project repre-
sents an option for increase of antibiotics prescription quality using the prescribing 
practitioners’ education. Analysis of prescription habits is suitable not only for cost 
control but also for antibiotics prescription implications on resistance trends. Long-
term integrated educational program leads to prescription habits change and better 
quality of care.
PRS46
TEN YEAR TRENDS IN PRESCRIPTION OF CHRONIC OBSTRUCTIVE 
PULMONARY MEDICATION AMONG ADULTS FROM 1996 TO 2005
Mehta H, Patel J, Parikh R, Aparasu RR, Sherer J
University of Houston, Houston, TX, USA
OBJECTIVES: Many guidelines were released during the past decade which tried to 
explain appropriate drug use for patients diagnosed with COPD. Medication use in 
COPD is also associated with issues related to adherence and side effects. The purpose 
of this study was to determine trends in prescription of COPD drugs in ambulatory 
setting and assess the rate of change in different drug classes. METHODS: We com-
bined National Ambulatory Care Settings (NAMCS) and National Hospital Ambula-
tory Care Settings (NHAMCS) data from year 1996 to 2005. For trend analysis, data 
were stratiﬁed in 2-year periods. All adult visits with only primary diagnosis of COPD 
(ICD-9-CM: 491, 492, 496) were included in analysis and drug categories were identi-
ﬁed using National Drug Codes. Descriptive analysis was carried out to determine 
patterns in drug prescription across years and four separate multivariate logistic 
models, dependent variable being drug class and independent variable being year, were 
constructed to identify rate of change in drug use across years while controlling for 
age, race, sex and smoking status. RESULTS: From 1996–97 to 2004–05, total COPD 
visits have been increased from 0.59% to 0.77%; Prescription of anticholinergics and 
inhaled corticosteroids increased (17.47% to 33.48% and 12.63% to 35.19% respec-
tively), whereas beta-agonist had no upward trend (29.46% to 29.53%). In year 
1996–97, beta-agonist was the highly prescribed drug (29.46%) whereas in 2004–05, 
anticholinergics (33.48%) and inhaled corticosteroids (35.19%) were the top pre-
scribed medications. From year 1996 to 2005, prescription of anticholinergics (OR-
1.088; CI-1.029–1.151) and inhaled corticosteroids (OR-1.132; CI-1.065–1.203) 
increased, beta agonist use has decreased (OR-0.916; CI-0.866–0.969) whereas there 
was no change for systemic corticosteroids (OR-1.034; CI-0.979–1.092). CONCLU-
SIONS: Overall drug utilization for COPD is increasing steadily. Use of bronchodila-
tors is increasing which is in accordance with Global initiative for Chronic Obstructive 
Lung Disease (GOLD) guidelines. Corticosteroid use which is increasing should be 
based on risk to beneﬁt ratio.
RESPIRATORY-RELATED DISORDERS – Conceptual Papers & Research on 
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COMPARING RISK ADJUSTMENT MODELS: PROPENSITY SCORE 
MATCHING, STANDARD REGRESSION ANALYSIS AND INSTRUMENTAL 
VARIABLE METHOD
Baser O1, Dysinger A2, Baser E2
1STATinMED Research / University of Michigan, Ann Arbor, MI, USA, 2STATinMED 
Research, Ann Arbor, MI, USA
OBJECTIVES: To compare three common risk adjustment models when estimating 
health care costs. METHODS: Using data from U.S. claims databases, the effect of 
treatment on total health care expenditures among asthma patients was estimated. 
Reimbursement amounts were dollars paid by the health plan to the provider including 
patient co-payments and deductibles. Doctors’ prescribing patterns were used as an 
instrumental variable for treatment choice. Propensity score matching was employed 
using the nearest neighbor matching algorithm. Generalized linear model was used as 
an alternative risk adjustment technique. RESULTS: Patients treated with control 
medication were younger, more likely to live in the northeast and south of the United 
States and have a higher Charlson comorbidity score, Elixhauser score and chronic 
disease score relative to patients treated with reliever medication. The difference 
between one year health care costs for reliever and controller medication was $2,345 
by propensity score matching, $2,195 by generalized linear model, and $2,997 by 
instrumental variable approach. The difference was statistically signiﬁcant. CONCLU-
SIONS: After adjusting for patient clinical and demographic characteristics, controller 
medication was less costly than reliever medication. The choice of risk adjustment was 
important. The technique that controlled for both observed and unobserved biases 
(instrumental variable technique) provided a difference of almost 30% higher than 
the other techniques.
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ASSESSING THE TIME-DEPENDENT NATURE OF COMORBIDITY 
INFLUENCE IN COPD
Kiri VA1, MacKenzie G2
1PAREXEL International, Uxbridge, London, UK, 2University of Limerick, Limerick, Ireland
OBJECTIVES In most outcome studies, comorbidity inﬂuence is modelled as constant 
with inherent assumptions that the duration of the condition does not inﬂuence 
prognosis and the effect persists. We challenge these assumptions as we demonstrate 
the time-dependent nature of the inﬂuence of certain comorbidities on patient survival. 
METHODS A retrospective cohort of 23,881 patients aged 50+ in the UK-GPRD at 
time of incident COPD diagnosis between 1990 and 1998 provided an appropriate 
setting. Each death patient was matched to as many survivors from the same practice 
as possible, of same age, sex and COPD duration. Some 18 binary comorbidities 
measured at the time of death were analysed in relation to mortality. Using conditional 
logistic regression model, we estimated hazard ratio (HR) for each comorbidity, 
adjusted for key baseline characteristics in two different models: In model A, we 
treated comorbidities as constant variables, whilst in B, we stratiﬁed each into two 
time-dependent categorical variables. We retained interactions between comorbidities 
which were signiﬁcant. RESULTS Some 2938 dead patients were matched to 5792 
survivors. We found evidence of time-dependent effects on risk for all but peripheral 
vascular disease and diabetes. Only in model B did we ﬁnd evidence for peptic ulcer, 
moderate/severe liver disease and hemiplagia/paraplagia. The liver disease effect was 
signiﬁcant only in those diagnosed within a year of death (HR > 15; p = 0.0162), 
where as the hemiplagia/paraplagia effect was found only in those diagnosed over a 
year ago (HR > 1.6; p = 0.0163). CONCLUSIONS To adequately adjust for comorbid-
ity inﬂuence in outcome studies, we recommend stratiﬁcation of each comorbidity on 
the basis of its duration (at start of follow-up for a cohort, or at time of outcome for 
a case-control study) to test for possible time-dependent effect. Adopting such 
approach as part of the exploratory analysis may improve the model and lead to more 
accurate estimations
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COMPARISON OF TWO METHODS FOR COVARIATE ADJUSTMENT 
WHEN ASSESSING HEALTH OUTCOMES IN THE U.S. HOSPITAL 
INPATIENT SETTING
Garvert W, Gemmen E, Bharmal M
Quintiles, Falls Church, VA, USA
OBJECTIVES: Demonstrate the differences in results from the use of two different 
methods for covariate adjustment when calculating differences in outcomes between 
groups. METHODS: The 2006 Nationwide Inpatient Sample hospital database was 
analyzed to estimate the clinical and economic impact to U.S. hospitals of air leaks 
during post-operative pulmonary surgery. For all stays with pulmonary surgery, length 
of stay (LOS), total charges, and in-hospital mortality rates were compared between 
stays including an air leak vs. stays without an air leak, while using two different 
methods to adjust for covariates: 1) multivariate regression analysis (ordinary least 
square regression for LOS and total charges, and logistic regression for in-hospital 
mortality) while controlling for age, gender, and hospital region; 2) 1:1 matched case-
